Navigation Links
Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
Date:8/12/2008

Medarex to Receive Milestone Payment from MedImmune

PRINCETON, N.J., Aug. 12 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that its partner MedImmune, Inc. has initiated a Phase 2A multi-dose clinical trial of MEDI-545 for the potential treatment of systemic lupus erythematosus (SLE or lupus). MEDI-545 is a fully human antibody generated by Medarex's UltiMAb Human Antibody Development System(R). Under the terms of the agreement, Medarex will receive a milestone payment of an undisclosed amount.

The Phase 2A clinical trial is designed to evaluate the safety and tolerability of multiple subcutaneous dose schedules of MEDI-545 or placebo in adult patients with moderate to severe active lupus. The study will also assess the effects of MEDI-545 on disease activity in lupus patients. This randomized, double-blind, placebo-controlled trial is expected to enroll 80 patients and will be conducted at 20 sites in the United States.

MedImmune is also conducting a Phase 1 clinical trial for MEDI-545 in idiopathic inflammatory myositis, an immunological disease that involves chronic muscle inflammation, pain and weakness.

"Data from an earlier reported placebo-controlled Phase 1 study suggested therapeutic activity with single doses in patients with lupus and demonstrated an acceptable safety profile," said Geoffrey M. Nichol, M.B.Ch.B., Senior Vice President of Product Development at Medarex. "We are very excited about the role of the interferon alpha inflammatory pathway and look forward to exploring its potential in treating patients with lupus and other autoimmune diseases."

About MEDI-545

MEDI-545 (previously known as MDX-1103) is a fully human monoclonal antibody targeting
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
7. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
8. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Inc. (OTCQB:ECIA), a medical device company owning patented surgical ... invasive surgery, today announced financial results for its fiscal ... 2015. The Company posted quarterly net revenue ... $349 thousand, or $(0.03) per share. These results compare ... loss of $1.453 million, or $(0.14) per share, in ...
(Date:5/27/2015)... , May 27, 2015 Biosensors International Group, ... Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer ... its fourth fiscal quarter ("Q4 FY15") and fiscal full ... Highlights and Recent Developments: , Q4 FY15: ... from the fourth quarter of Fiscal Year 2014 ("Q4 ...
(Date:5/27/2015)... , May 27, 2015 AtCor Medical ... SphygmoCor ® system which measures central aortic blood ... a panel US medical experts for physicians on the ... patient care. The article, "Clinical Use of Pulse ... American Artery " was published in the Journal of ...
Breaking Medicine Technology:Encision Reports Fourth Quarter And Fiscal Year 2015 Results 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 4Encision Reports Fourth Quarter And Fiscal Year 2015 Results 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 6Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7Expert panel publishes guidance for central aortic pressure waveform analysis in patient care 2Expert panel publishes guidance for central aortic pressure waveform analysis in patient care 3
(Date:5/27/2015)... Danish scientists have published an analysis of ... potential to help in diagnosis or treatment planning for ... that has just been posted on Surviving Mesothelioma. ... new biomarkers found in blood, serum, and lung fluid ... malignant mesothelioma . , Study author Vasiliki Panou ...
(Date:5/27/2015)... 2015 The Society for Women's ... thought leader in research on sex differences in health ... campaign uniting survivors, advocates, organizations, and celebrities in bringing ... disease. The campaign features a short film that ... with chronic disease as a result of their abuse, ...
(Date:5/27/2015)... National Healthcare Providers (NHCP), ... web development and interactive marketing agency, Bayshore ... of its newly redesigned, custom website, found ... Providers, is a physician owned and operated ... of Radiology, Anesthesiology, Emergency and Hospital Medicine. ...
(Date:5/27/2015)... MD (PRWEB) May 27, 2015 ... USA, helped its client to launch an Android version ... allows merchants to accept credit, debit and ACH payments ... from Google Play at: https://play.google.com/store/apps/details?id=com.simpalm.paymentgateway . The iOS ... and has been recently updated by SIMpalm. , ...
(Date:5/27/2015)... This year, Mental Health America (MHA) is ... affected to seek assistance before a crisis occurs. According to ... five children, ages 13 to 18, are living with or ... of mental illness within one's lifetime will begin by age ... help before reaching a critical stage — particularly for young ...
Breaking Medicine News(10 mins):Health News:New Report Highlights Current and Emerging Biomarkers for Mesothelioma, According to Surviving Mesothelioma 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3Health News:Forte Payment System Launches Android Version of Payment App 2Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3
... June 2010: Smoking cigarettes is a significant risk factor ... negative impact on the effectiveness of anti-tumour necrosis factor ... to results of two studies presented today at EULAR ... Rheumatism in Rome, Italy. A further study has shown ...
... ... CA will be an exciting event for Tosoh Bioscience (Booth #7714) as the company plans to ... and HPLC testing. , ... 2010 -- The AACC 2010 Annual Meeting in Anaheim, CA will be an exciting ...
... ... National Society of Certified Healthcare Business Consultants to Focus on Shared Goals of EHR ... ... of the integrated, single-database electronic health record (EHR), practice management and interoperability solution PrimeSuite®, ...
... after new rules took effect, study finds , THURSDAY, ... to doctors who administer outpatient chemotherapy drugs actually led ... finds a new study. , "This sort of dynamic ... economists often encounter this sort of thing," Joseph Newhouse, ...
... , ... Nutrition, LLC, an innovative, technology-enhanced, nutrition company, announced today that it is expanding their ... newest member to join this highly-respected team of doctors and scientists. , ... (PRWEB) June 17, 2010 ...
... , ... Themedicalsupplydepot.com, a rapidly growing online medical supplies superstore, announces a ... supplies provider—from super lightweight wheelchairs to diabetic test supplies—can be purchased easily ... ...
Cached Medicine News:Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 3Health News:AACC 2010 Creates Excitement for Tosoh Immunoassay and HPLC Analyzers 2Health News:Greenway Partners with National Healthcare Consultancy 2Health News:Greenway Partners with National Healthcare Consultancy 3Health News:Medicare Cuts May Have Led Docs to Prescribe More Chemo 2Health News:Discount Medical Supplies Provider Now Offering International Checkout 2
The WADiana Compact is a fully automated immuno-haematology analyser, easy to use with maximum security including clot detection and ensuring no contamination....
... PK7200 works on patented microplate agglutination ... testing system for donor ABO/Rh testing. PK7200 ... syphilis and cytomegalovirus antibody detection. The Automated ... along with the proven reliability that for ...
... Tecan Haemotyper is an automated ... The Tecan Haemotyper combines a ... platform with the DiaMed agglutination ... process DiaMed-ID cards and microplates ...
... the "Reversed" shoulder prosthesis has been used ... More recently, an ever-growing number of surgeons ... champion this prosthesis and the associated surgical ... technology is the result of nearly fifteen ...
Medicine Products: